{"id":"magnesium-pidolate","rwe":[{"pmid":"37375733","year":"2023","title":"Compounded Effervescent Magnesium for Familial Hypomagnesemia: A Case Report.","finding":"","journal":"Pharmaceuticals (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"36769401","year":"2023","title":"Calcineurin-Inhibitor-Induced Hypomagnesemia in Kidney Transplant Patients: A Monocentric Comparative Study between Sucrosomial Magnesium and Magnesium Pidolate Supplementation.","finding":"","journal":"Journal of clinical medicine","studyType":"Clinical Study"},{"pmid":"32878232","year":"2020","title":"Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate.","finding":"","journal":"Nutrients","studyType":"Clinical Study"},{"pmid":"31503002","year":"2019","title":"Magnesium and the blood-brain barrier in vitro: effects on permeability and magnesium transport.","finding":"","journal":"Magnesium research","studyType":"Clinical Study"},{"pmid":"31498421","year":"2019","title":"Magnesium for treating sickle cell disease.","finding":"","journal":"The Cochrane database of systematic reviews","studyType":"Clinical Study"}],"tags":[{"label":"magnesium pidolate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A12CC08","category":"atc"},{"label":"Active","category":"status"}],"phase":"discontinued","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"pidolic acid magnesium salt","offLabel":[],"synonyms":["magnesium pidolate","pidolic acid magnesium salt"],"timeline":[],"approvals":[],"brandName":"Pidolic Acid Magnesium Salt","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"magnesium pidolate","explanation":"Think of magnesium as a key that helps many of the body's functions work properly. Magnesium pidolate helps supply this key, which can be especially important for people who don't get enough magnesium from their diet. This can help with muscle and nerve function, as well as other bodily processes.","oneSentence":"Magnesium pidolate works by providing the body with magnesium ions, which are essential for various cellular processes.","technicalDetail":"Magnesium pidolate acts as a magnesium ion donor, releasing magnesium ions in the body to support cellular functions, including muscle contraction, nerve impulse transmission, and energy production."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4597","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=MAGNESIUM%20PIDOLATE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MAGNESIUM PIDOLATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:29:26.763359","biosimilars":[],"competitors":[{"drugName":"magnesium chloride","drugSlug":"magnesium-chloride","fdaApproval":"1975-08-13","relationship":"same-class"},{"drugName":"magnesium sulfate","drugSlug":"magnesium-sulfate","fdaApproval":"1981-10-06","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"magnesium citrate","drugSlug":"magnesium-citrate","fdaApproval":"","relationship":"same-class"},{"drugName":"magnesium oxide","drugSlug":"magnesium-oxide","fdaApproval":"1982-06-22","relationship":"same-class"}],"genericName":"magnesium pidolate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"magnesium-chloride","brandName":"magnesium chloride","genericName":"magnesium chloride","approvalYear":"1975","relationship":"same-class"},{"drugId":"magnesium-sulfate","brandName":"magnesium sulfate","genericName":"magnesium sulfate","approvalYear":"1981","relationship":"same-class"},{"drugId":"magnesium-citrate","brandName":"magnesium citrate","genericName":"magnesium citrate","approvalYear":"","relationship":"same-class"},{"drugId":"magnesium-oxide","brandName":"magnesium oxide","genericName":"magnesium oxide","approvalYear":"1982","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT05220917","phase":"","title":"Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-08-01","conditions":["Cardiovascular Events","Type2 Diabetes","Renal Disease"],"enrollment":781430,"completionDate":"2026-07-01"},{"nctId":"NCT06261320","phase":"PHASE2","title":"Mesotherapy Treatment of Irritable Bowel Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Polyclinique de l'Europe","startDate":"2024-02-28","conditions":["Inflammatory Bowel Diseases"],"enrollment":27,"completionDate":"2027-01-31"},{"nctId":"NCT05523791","phase":"NA","title":"Whey Protein Supplementation in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Ospedale Generale Di Zona Moriggia-Pelascini","startDate":"2022-01-01","conditions":["Parkinson Disease"],"enrollment":51,"completionDate":"2022-06-30"},{"nctId":"NCT00143572","phase":"PHASE1","title":"Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell Disease","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2004-11","conditions":["Anemia, Sickle Cell"],"enrollment":16,"completionDate":"2008-01"},{"nctId":"NCT01181830","phase":"PHASE4","title":"Effect of Magnesium Administration in Subjects With Family History of Diabetes or Metabolic Syndrome","status":"COMPLETED","sponsor":"Universita di Verona","startDate":"2010-02","conditions":["Family History of Metabolic Syndrome","Family History of Diabetes"],"enrollment":14,"completionDate":"2012-12"},{"nctId":"NCT00532883","phase":"PHASE2","title":"Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease","status":"TERMINATED","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-01","conditions":["Hemoglobin SC Disease"],"enrollment":44,"completionDate":"2009-08"},{"nctId":"NCT00040456","phase":"PHASE2","title":"Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate","status":"TERMINATED","sponsor":"Baylor College of Medicine","startDate":"2001-01","conditions":["HEMOGLOBIN SC DISEASE"],"enrollment":12,"completionDate":"2006-05"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"003855","UNII":"V5PC588N7G","RXNORM":"116240","UMLSCUI":"C0381600","ChEMBL_ID":"CHEMBL3707303","PUBCHEM_CID":"18601084","SECONDARY_CAS_RN":"62003-27-4","MESH_DESCRIPTOR_UI":"D011761"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":28,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"A12CC08","allCodes":["A12CC08"]},"biosimilarFilings":[],"recentPublications":[{"date":"2023 May 24","pmid":"37375733","title":"Compounded Effervescent Magnesium for Familial Hypomagnesemia: A Case Report.","journal":"Pharmaceuticals (Basel, Switzerland)"},{"date":"2023 Jan 17","pmid":"36769401","title":"Calcineurin-Inhibitor-Induced Hypomagnesemia in Kidney Transplant Patients: A Monocentric Comparative Study between Sucrosomial Magnesium and Magnesium Pidolate Supplementation.","journal":"Journal of clinical medicine"},{"date":"2020 Aug 31","pmid":"32878232","title":"Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate.","journal":"Nutrients"},{"date":"2019 Feb 1","pmid":"31503002","title":"Magnesium and the blood-brain barrier in vitro: effects on permeability and magnesium transport.","journal":"Magnesium research"},{"date":"2019 Sep 9","pmid":"31498421","title":"Magnesium for treating sickle cell disease.","journal":"The Cochrane database of systematic reviews"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"discontinued","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Magnesium pidolate is a small molecule drug belonging to the magnesium pidolate class. Its original development and current ownership are not specified. The target and approved indications of magnesium pidolate are unknown. It is not clear if it is FDA approved or off-patent. Further information on its commercial status and key safety considerations is required.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}